-
Aziz M, Fatima R, Assaly R, 2020: Elevated interleukin-6 and severe COVID-19: a meta-analysis[J]. J Med Virol, 92, 2283-2285. doi: 10.1002/jmv.25948
-
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q, 2020a: Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study[J]. BMJ-Brit Med J, 368, m1295-.
-
Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, Men D, Huang Q, Liu Y, Yang B, Ding J, Li F, 2020b: Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) Is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019[J]. Clin Infect Dis, 71, 1937-1942. doi: 10.1093/cid/ciaa449
-
Fu YJ, Cheng YX, Wu YT, 2020: Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools[J]. Virol Sin, 35, 266-271. doi: 10.1007/s12250-020-00207-4
-
Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, Haagmans BL, Lauber C, Leontovich AM, Neuman BW, Penzar D, Perlman S, Poon LLM, Samborskiy DV, Sidorov IA, Sola I, Ziebuhr J, Coronaviridae Study G, 2020: The species severe acute respiratory syndrome-related coronavirus classifying 2019-nCoV and naming it SARS-CoV-2[J]. Nat Microbiol, 5, 536-544. doi: 10.1038/s41564-020-0695-z
-
Grifoni E, Valoriani A, Cei F, Lamanna R, Gelli AMG, Ciambotti B, Vannucchi V, Moroni F, Pelagatti L, Tarquini R, Landini G, Vanni S, Masotti L, 2020: Interleukin-6 as prognosticator in patients with COVID-19[J]. J Infect, 81, 466-467.
-
Guan WY, Lan WD, Zhang J, Zhao S, Ou JX, Wu XW, Yan YQ, Wu JG, Zhang QW, 2020: COVID-19: antiviral agents, antibody development and traditional chinese medicine[J]. Virol Sin, 35, 685-698. doi: 10.1007/s12250-020-00297-0
-
Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C, Xia Y, 2020: Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors[J]. Emerg Microbes Infect, 9, 1123-1130. doi: 10.1080/22221751.2020.1770129
-
Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, Klein M, Weinberger T, 2020: Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19[J]. J Allergy Clin Immunol, 146, 128-136. doi: 10.1016/j.jaci.2020.05.008
-
Huang CL, Wang YM, Li X, Ren LL, Gu XY, Kang L, Guo L, Liu M, Zhou X, Luo JF, Huang ZH, Tu SJ, Zhao Y, Chen L, Xu DC, Li YP, Li CH, Peng L, Li Y, Xie WX, Cui D, Shang LH, Fan GH, Xu JY, Wang G, Wang Y, Zhong JC, Wang C, Wang JW, Zhang DY, Cao B, 2021: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study[J]. Lancet, 397, 220-232. doi: 10.1016/S0140-6736(20)32656-8
-
Laguna-Goya R, Utrero-Rico A, Talayero P, Lasa-Lazaro M, Ramirez-Fernandez A, Naranjo L, Segura-Tudela A, Cabrera-Marante O, Rodriguez de Frias E, Garcia-Garcia R, Fernandez-Ruiz M, Maria Aguado J, Martinez-Lopez J, Ana Lopez E, Catalan M, Serrano A, Paz-Artal E, 2020: IL-6-based mortality risk model for hospitalized patients with COVID-19[J]. J Allergy Clin Immunol, 146, 799-807. doi: 10.1016/j.jaci.2020.07.009
-
Li TB, Huang T, Guo C, Wang AL, Shi XL, Mo XF, Lu QQ, Sun J, Hui TT, Tian G, Wang LY, Yang JL, 2021: Genomic variation, origin tracing, and vaccine development of SARS-CoV-2L: a systematic review[J]. The Innov, 2, 100116-.
-
Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, Li B, Song X, Zhou X, 2020a: Prognostic value of interleukin-6, C -reactive protein, patients with COVID-19 and procalcitonin in patients with COVID-19[J]. J Clin Virol, 127, 104370-. doi: 10.1016/j.jcv.2020.104370
-
Liu T, Zhang J, Yang Y, Ma H, Li Z, Zhang J, Cheng J, Zhang X, Zhao Y, Xia Z, Zhang L, Wu G, Yi J, 2020b: The role of interleukin-6 in monitoring severe case of coronavirus disease 2019[J]. EMBO Mol Med, 12, e12421-.
-
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, Speciality HLHA, 2020: COVID-19: consider cytokine storm syndromes and immunosuppression[J]. Lancet, 395, 1033-1034. doi: 10.1016/S0140-6736(20)30628-0
-
Moore JB, June CH, 2020: Cytokine release syndrome in severe COVID-19[J]. Science, 368, 473-474. doi: 10.1126/science.abb8925
-
Ruan Q, Yang K, Wang W, Jiang L, Song J, 2020: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China[J]. Intensive Care Med, 46, 846-848. doi: 10.1007/s00134-020-05991-x
-
Ulhaq ZS, Soraya GV, 2020: Interleukin-6 as a potential biomarker of COVID-19 progression[J]. Med Mal Infect, 50, 382-383. doi: 10.1016/j.medmal.2020.04.002
-
Velazquez-Salinas L, Verdugo-Rodriguez A, Rodriguez LL, Borca MV, 2019: The role of interleukin 6 during viral infections[J]. Front Microbiol, 10, 1057-. doi: 10.3389/fmicb.2019.01057
-
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B, 2020: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. Lancet, 395, 1054-1062. doi: 10.1016/S0140-6736(20)30566-3
-
Zhu Z, Cai T, Fan L, Lou K, Hua X, Huang Z, Gao G, 2020: Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019[J]. Int J Infect Dis, 95, 332-339. doi: 10.1016/j.ijid.2020.04.041